Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (201-210 of 621) with videos related to

Pageof 63
Sort By:
The Lancet. Rheumatology|July 27, 2022
Systemic sclerosis in the time of COVID-19Anna-Maria Hoffmann-Vold, Oliver Distler, Cosimo Bruni, et al.
RMD Open|February 23, 2025
Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Frontiers in Psychology|March 10, 2021
No Evidence for a Decrease in Physical Activity Among Swiss Office Workers During COVID-19: A Longitudinal StudyAndrea Martina Aegerter, Manja Deforth, Gisela Sjøgaard, et al.
RMD Open|October 21, 2022
Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registryRaphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Annals of the Rheumatic Diseases|March 31, 2015
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologiesClara Dees, Christian Beyer, Alfiya Distler, et al.
Biomedicines|December 23, 2023
BRD3 Regulates the Inflammatory and Stress Response in Rheumatoid Arthritis Synovial FibroblastsTanja Seifritz, Matthias Brunner, Eva Camarillo Retamosa, et al.
Annals of the Rheumatic Diseases|April 24, 2012
Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosisBritta Maurer, Nicole Reich, Astrid Juengel, et al.
Clinical and Experimental Rheumatology|March 10, 2011
Microparticles and Kawasaki disease: a marker of vascular damage?Serena Guiducci, Laura Ricci, Eloisa Romano, et al.
Journal of Scleroderma and Related Disorders|August 1, 2025
The serum levels of specific autoantibodies in systemic sclerosis predict a more severe skin involvementHannah Dengler, Maya Vonow-Eisenring, Mike Oliver Becker, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosisThomas Wohlfahrt, Svetlana Usherenko, Matthias Englbrecht, et al.
Pageof 63

Showing results (201-210 of 621) with videos related to

Sort By:
Pageof 63
The Lancet. Rheumatology|July 27, 2022
Systemic sclerosis in the time of COVID-19Anna-Maria Hoffmann-Vold, Oliver Distler, Cosimo Bruni, et al.
RMD Open|February 23, 2025
Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Frontiers in Psychology|March 10, 2021
No Evidence for a Decrease in Physical Activity Among Swiss Office Workers During COVID-19: A Longitudinal StudyAndrea Martina Aegerter, Manja Deforth, Gisela Sjøgaard, et al.
RMD Open|October 21, 2022
Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registryRaphael Micheroli, Seraphina Kissling, Kristina Bürki, et al.
Annals of the Rheumatic Diseases|March 31, 2015
Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologiesClara Dees, Christian Beyer, Alfiya Distler, et al.
Biomedicines|December 23, 2023
BRD3 Regulates the Inflammatory and Stress Response in Rheumatoid Arthritis Synovial FibroblastsTanja Seifritz, Matthias Brunner, Eva Camarillo Retamosa, et al.
Annals of the Rheumatic Diseases|April 24, 2012
Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosisBritta Maurer, Nicole Reich, Astrid Juengel, et al.
Clinical and Experimental Rheumatology|March 10, 2011
Microparticles and Kawasaki disease: a marker of vascular damage?Serena Guiducci, Laura Ricci, Eloisa Romano, et al.
Journal of Scleroderma and Related Disorders|August 1, 2025
The serum levels of specific autoantibodies in systemic sclerosis predict a more severe skin involvementHannah Dengler, Maya Vonow-Eisenring, Mike Oliver Becker, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosisThomas Wohlfahrt, Svetlana Usherenko, Matthias Englbrecht, et al.
Pageof 63